The global Real-Time Polymerase Chain Reaction Market size was USD 4.64 Billion in 2021 and is expected to register a revenue CAGR of 7.8% over the forecast period, according to the latest report by Reports and Data. Increasing adoption of qPCR in medical diagnosis and new product launches are key factors driving market revenue growth. In addition, rising cases of chronic diseases, such as cancer, hepatitis, Human Immunodeficiency Virus (HIV), and many others, are also driving market revenue growth. For instance, according to World Health Organization (WHO), an estimated 354 million people living worldwide live with hepatitis C or hepatitis B. By 2030, hepatitis-related premature deaths in low- and middle-income countries might be reduced by an estimated 4.5 million owing to treatment kits such as qPCR, medications, and others.
Recent technological advancements, investments in research, and launch of new products are other factors driving qPCR market revenue growth. For instance, on 27 October 2021, Azure Biosystems, a provider of innovative bioanalytical solutions for protein and cell biology announced to distribute Azure Cielo Dx in European Union (EU) for In Vitro Diagnostic (IVD) use. Azure Cielo 3 Dx and Azure Cielo 6 Dx are real-time PCR systems that adhere to EU's In Vitro Diagnostic Directive (IVDD) for 3 and 6-channel nucleic acid detection respectively. A 10.3" touch screen interface with simple software makes it simple to start up, which runs and checks if run status controls the instrument. In addition, small device supports data transfer over USB, ethernet, and Wi-Fi. The system includes Azure Cielo Manager software, which provides a full workflow solution for real-time PCR run setup and data processing.
Get a sample copy of the global Real-Time Polymerase Chain Reactions market report @ https://www.reportsanddata.com/download-free-sample/5500
Some Key Highlights From the Report
- On 9 November 2020, Streck, headquartered in the U.S., which develops and manufactures products in hematology, immunology, molecular diagnostics, cell stabilization, infectious diseases, and urinalysis for clinical and research laboratories announced to launch Zulu RT, which is a rapid, modular qPCR instrument capable of performing four independent experiments simultaneously. It can complete a 40-cycle, 6-channel, 3-step real-time PCR in less than 20 minutes. In addition, Zulu RT combines exclusive, proprietary thermal technology from Streck with potent optics. Moreover, it can do rapid, six-color detection faster than any other conventional instrument and has excellent thermal management.
- The reagents and consumables segment accounted for largest revenue share in 2021. This is due to affordability of core kits when compared to master mixes, freedom to design customized reaction protocols, expansion of private and public funding for life science research, and expansion of market accessibility of qPCR kits in developed countries.
- The blood and oncology segment accounted for largest revenue share in 2021 due to increasing adoption of infectious and genetic disorders such as hepatitis, HIV, and cancer. According to HIV.gov, In 2021, 85% of all HIV-positive individuals knew that they have HIV. HIV testing is a key entry point for HIV prevention, care, treatment, and support services.
- The North America market accounted for largest revenue share in 2021. Increasing investments in healthcare and launch of new products are major factors driving market revenue growth. The U.S. is expected to lead regional demand owing to the presence of market participants such as Abbott, Thermo Fisher Scientific, Agilent Technologies, and many others. In addition, increased penetration of qPCR in diagnosing infectious diseases, such as HIV, malaria, and others, is driving market revenue growth.
Leading Players in the Global Pharma Healthcare Market:
Abbott, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, F. Hoffman-La Roche Ltd, BD, Agilent Technologies Inc., Integrated DNA Technologies Inc., Standard BioTools, Takara Bio Inc., and Lumex Instruments.
Product Type Outlook (Revenue, USD Billion; 2019–2030)
- Reagents and Consumables
- Instruments
- Software and Services
Application Outlook (Revenue, USD Billion; 2019–2030)
- Blood and Oncology Testing
- Pathogen Testing
- Research and Development
- Forensic Testing
- Others
End-Use Outlook (Revenue, USD Billion; 2019–2030)
- Hospitals
- Research Laboratories and Academic Institutes
- Diagnostic Centers
- Clinical Research Organizations (CROs)
- Forensic Laboratories
- Pharma and Biotech Companies
- Others
Regional Outlook of the Global Real-Time Polymerase Chain Reactions Market:
Under this section of the report, the authors comprehensively analyze the key regional markets in the global Real-Time Polymerase Chain Reactions market. This section accurately evaluates the revenue shares and year-on-year revenue growth rate of these regional markets. Key regional markets encompassed in the report include North America, Europe, Asia Pacific, Latin America, and the Middle East Africa.
Detailed Regional Market Segmentation
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
Key points covered in the global Real-Time Polymerase Chain Reactions market report:
- The report presents a detailed study of the global Real-Time Polymerase Chain Reactions market
- It specializes in the study of the major market dynamics including driving and restraining market growth, latest product trends, and latest technological advancements
- The report offers detailed market segmentation based on product type, application spectrum, and end-use landscape, and distribution channel
- It focuses on the latest product developments and company profiles of the market’s leading players
Request a customized copy of the Real-Time Polymerase Chain Reactions market report @ https://www.reportsanddata.com/request-customization-form/5500
In conclusion, the qPCR market is expected to grow at a significant pace during the forecast period due to the increasing demand for advanced diagnostic techniques, the growing research and development activities in the life science and biotechnology industries, and the
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Get Explore Latest Research Report by Reports and Data:
Anatomic Pathology Market @ https://www.biospace.com/article/anatomic-pathology-market-is-expected-to-reach-usd-56-22-billion-by-2028-at-a-cagr-of-6-3-percent-reports-and-data/
Pericarditis Market @ https://www.biospace.com/article/increase-in-awareness-of-heart-health-and-growing-investments-by-pharmaceutical-companies-is-expected-to-drive-the-growth-of-pericarditis-market/
Biosimilar Of Remicade Market @ https://www.biospace.com/article/biosimilar-of-remicade-market-trends-revenue-key-players-growth-share-and-forecast-till-2028-/
Bacterial Conjunctivitis Market @ https://www.biospace.com/article/bacterial-conjunctivitis-market-trends-revenue-key-players-growth-share-and-forecast-till-2027/
http://dir.portokal-bg.net/counter.php?redirect=https://www.reportsanddata.com/
https://tracker.onrecruit.net/api/v1/redirect/?redirect_to=https://www.reportsanddata.com/
http://chipmanuals.com/url.php?url=https://www.reportsanddata.com/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
